2 completed, 1 terminated, 1 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Gefarnate: new trials by email Literature Review of Gefarnate trials Research Report on Gefarnate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia Gefarnate, Statin - Coronary Artery Disease | Phase 2 / Phase 3 | Unknown | First Affiliated Hospital of Harbin Medical University | 70 | 2019-09-01 | 2020-07-30 |
| Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation Low-dose PPI (Rabeprazole sodium), High-dose PPI (Rabeprazole sodium), Non-PPI (Gefarnate) - Cardio-cerebrovascular Disease | Phase 3 | Completed | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 280 | 2008-08-01 | 2011-04-04 |
| A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers Lansoprazole, Gefarnate - Stomach Ulcer, Duodenal Ulcer | Phase 3 | Terminated | Takeda | 461 | 2007-05-01 | 2012-02-03 |
| Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs Lansoprazole, Gefarnate - Stomach Ulcer, Duodenal Ulcer | Phase 3 | Completed | Takeda | 366 | 2007-04-01 | 2012-02-03 |
Duodenal Ulcer (2) · Stomach Ulcer (2) · Coronary Artery Disease (1)
Takeda (2) · First Affiliated Hospital of Harbin Medical University (1) · Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1)
Japan (3) · China (1)